On Wednesday, Ford Motor Company (NYSE:F)’s shares inclined 1.53% to $14.97.
Ford Motor Company (F) has beta value of 1.31. The company has the market capitalization of $59.06 billion. Return on assets ratio of the company was 1.70% while its return on equity ratio was 14.50%. ATR value of company was 0.35 while stock volatility for week was 1.90% while for month was 2.00%. Debt to equity ratio of the company was -4.69.
Ford is recalling 129,000 midsize SUVs in parts of the U.S. and Canada to fix potential fuel leaks, according to AP.
The company says the recall covers the 2009 and 2010 Ford Edge and Lincoln MKX.
In places where salt is used to clear the roads of snow, the fuel tanks can rust under the reinforcement brackets that hold them to the SUVs. This can cause a fuel leak or activate the check engine light. A leak could cause a fire.
Ford says it doesn’t know of any fires caused by the problem.
Dealers will inspect the fuel tanks and repair or replace them at no cost to customers. AP Reports
Ford Motor Company (Ford) manufactures or distributes automobiles across six continents. The Company operates in two sectors: Automotive and Financial Services. Automotive sector comprises North America, South America, Europe, Middle East & Africa, and Asia Pacific segments.
Endologix, Inc. (NASDAQ:ELGX)’s shares gained 3.53% to $9.08.
Endologix, Inc. (ELGX) offered -58.50% EPS for prior five years. The company has -44.00% return on equity value while its ROI ratio was -10.80%. The company has $594.51 million market capitalizations and the institutional ownership was 91.70%. Its price to book ratio was -5.75. Volatility of the stock was 10.18% for the week while for the month booked as 5.46%.
Endologix, declared the pricing of its underwritten public offering of $110.0 million aggregate principal amount of its convertible senior notes due 2020, which represents a decrease of $40.0 million from the aggregate principal amount of the Notes the Company formerly declared it was offering. The Company made the decision to reduce the size of the offering in light of market conditions and the price of the Company’s common stock at the time of pricing. The Company granted an option to the underwriter for up to an additional $15.0 million aggregate principal amount of the Notes solely to cover overallotments, if any. Piper Jaffray & Co. is acting as the sole underwriter for the offering.
Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company’s products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms: traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens.
At the end of Wednesday’s trade, Verisk Analytics, Inc. (NASDAQ:VRSK)‘s shares dipped -9.55% to $72.66.
Verisk Analytics, Inc. (VRSK) is currently valued at $13.53 billion. The company has 168.49 million shares outstanding and 91.20% shares of the company were owned by institutional investors. The company has 6.54 value in price to sale ratio while price to book ratio was recorded as -9.59. The company exchanged hands with 7.42 million shares as compared to its average daily volume of 2.27 million shares. It beta stands at 0.50.
Verisk Analytics, Inc. is a provider of information about risk to professionals in insurance, healthcare, financial services, Government, supply chain and risk administration. The Company provides predictive analytics and decision-support solutions in fraud prevention, actuarial science, insurance coverage’s, fire protection, catastrophe and weather risk, profitability optimization, data administration, among others.